Healthcare Sales & Marketing Network News: hypogonadism

Searching News Database: hypogonadism

HSMN NewsFeed - 14 Jun 2021
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2020
Lipocine Announces Regulatory Path Forward for TLANDO(TM) Resubmission
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Nov 2019
Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Jul 2019
Acerus And Aytu Bioscience To Co-Promote NATESTO(R) In The United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Jul 2019
Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 1 Dec 2017
TesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx's Oral Testosterone Product
Biopharmaceuticals Distribution

HSMN NewsFeed - 26 Oct 2017
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Biopharmaceuticals Urology Distribution

HSMN NewsFeed - 13 Jul 2017
Aytu BioScience Expands MiOXSYS(R) Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Diagnostics Urology Distribution

HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb�s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Oct 2016
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 Dec 2015
Acerus Announces Termination of NATESTO(TM) Agreement with Endo
Biopharmaceuticals Distribution

HSMN NewsFeed - 24 Nov 2015
European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo(R) European Marketing Authorization Application
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Nov 2015
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2014
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2014
Clarus Therapeutics Secures $31.5 Million in Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 May 2014
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2014
Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress
Biopharmaceuticals Urology

HSMN NewsFeed - 17 Mar 2014
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology

HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic

HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals

HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology

HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals

HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology

HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel�
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2011
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome
Biopharmaceuticals

HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Biopharmaceuticals

HSMN NewsFeed - 8 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2011
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2010
XIAFLEX(R) Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2010
Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2010
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Sep 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2009
QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Jun 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Apr 2009
XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals

HSMN NewsFeed - 14 Apr 2009
BioSante Announces Launch of Elestrin in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Dec 2008
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc to Acquire U.S. Rights to Elestrin (TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Sep 2008
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Jun 2008
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2008
Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2008
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jun 2008
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Biopharmaceuticals Licensing Urology

HSMN NewsFeed - 21 May 2008
QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals

HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2008
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2008
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2008
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2007
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 3 Oct 2007
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Sep 2007
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2007
Indevus Announces Submission of New Drug Application
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2007
Indevus Announces FDA Approval of SANCTURA(R) XR
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 25 Jul 2007
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2007
The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2007
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2007
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
Biopharmacceuticals

HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2007
Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
Biopharmaceuticals

HSMN NewsFeed - 31 May 2007
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 May 2007
Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
Biopharmaceuticals

HSMN NewsFeed - 3 May 2007
Indevus Announces FDA Approval of SUPPRELIN(R)-LA
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 19 Apr 2007
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
Indevus and Valera Announce Completion of Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Mar 2007
Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Feb 2007
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2006
Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2006
FDA Accepts New Drug Application for SANCTURA XR(TM) Submitted by Indevus
Biopharmaceuticals Urology

HSMN NewsFeed - 12 Dec 2006
Paladin and Auxilium Sign Exclusive Distribution Agreement for Testim'R'
Biopharmaceuticals Distribution

HSMN NewsFeed - 12 Dec 2006
Indevus Pharmaceuticals to Acquire Valera Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Dec 2006
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
Biopharmaceuticals Distribution

HSMN NewsFeed - 7 Dec 2006
James Meer Appointed Chief Financial Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Oct 2006
Indevus Announces the Finalization of Supply Agreement with Schering AG, Germany for NEBIDO(R)
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2006
Auxilium Pharmaceuticals Announces R&D Portfolio Change
Biopharmaceuticals

HSMN NewsFeed - 17 Oct 2006
Indevus Pharmaceuticals Announces Appointment of Thomas Farb as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2006
Indevus Announces Submission of New Drug Application Seeking Approval for SANCTURA XR to Treat Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA

HSMN NewsFeed - 26 Sep 2006
Indevus Announces Clinical and Regulatory Plans for Pagoclone
Biopharmaceuticals

HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 5 Sep 2006
Auxilium Pharmaceuticals Announces New Strategic Initiatives
Biopharmaceuticals

HSMN NewsFeed - 1 Aug 2006
Columbia Laboratories Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
Biopharmaceuticals

HSMN NewsFeed - 7 Jul 2006
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Auxilium Pharmaceuticals Announces Start of U.S. Phase III Pivotal Trial of Testosterone Transmucosal Film (AA2600) for Hypogonadism
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
Auxilium Appoints Armando Anido as Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2006
Auxilium Pharmaceuticals Announces Top-Line Results from a Pivotal Efficacy Study of AA4500 in Dupuytren's Disease and Revises 2006 Financial Guidance
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2006
Auxilium Pharmaceuticals Announces Top-Line Results From Phase IV Trial of Testim(R) in Patients With Type II Diabetes
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2006
Indevus Announces Positive Phase III Data for SANCTURA XR(TM)
Biopharmaceuticals Urology

HSMN NewsFeed - 12 Jun 2006
Data Presented at American Diabetes Association Annual Meeting Suggest Testosterone Levels Correlate with Insulin Resistance and Insulin Sensitivity in Type 2 Diabetes Patients
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
Indevus Announces Promising Phase II Data for Pagoclone In Stuttering
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 May 2006
Repros Therapeutics Provides Update for Ongoing Clinical Studies
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2006
Indevus Completes Enrollment in Second Phase III Trial for SANCTURA XR(TM)
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2006
Indevus Announces FDA Acceptance of IND for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Mar 2006
Robert S. Mills Elected Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2006
Indevus Files New Patent Application for the Use of Pagoclone in Premature Ejaculation
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Indevus Provides Update on Two Clinical Programs
Biopharmaceuticals

HSMN NewsFeed - 3 Feb 2006
Zonagen Announces Positive Top-Line Results of Androxal(TM) Study
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2006
Cellegy Announces Licensing Agreement With CONRAD and Other Events
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Jan 2006
Serono's Gonal-f(R) Approved in Japan for the Treatment of Male Hypogonadotropic Hypogonadism
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Jan 2006
Cellegy Renegotiates Tostrex(R) EU License and Distribution Agreement With ProStrakan Group plc
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jan 2006
Indevus Announces Closing of Delatestryl(R) Transaction
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Jan 2006
Cellegy Reports Cellegesic to Be Reviewed by the Cardio-Renal Advisory Committee in April 2006
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2006
Columbia Laboratories Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2006
Zonagen Receives IRB Approval to Commence Phase III Study of Androxal(TM) for the Treatment of Testosterone Deficiency
Biopharmaceuticals

Return to NewsFeed

Additional items found! 70

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 70 additional stories matching:
hypogonadism
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.